Effectiveness of rituximab for chemotherapy- resistant multiple tumoral B-LPD in a haemopoietic stem cell recipient

被引：2

作者：

Imashuku, S ^{[1
]}

Naya, M

Tamura, S

An, BM

Teramura, T

Kobayashi, M

Nomura, K

Taniwaki, M

机构：

[1] Kyoto City Inst Hlth & Environm Sci, Kyoto, Japan

[2] Kyoto City Hosp, Div Pediat, Kyoto, Japan

[3] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2002年 / 117卷 / 03期

关键词：

rituximab; post-transplant lymphoproliferative disorder; Epstein-Barr virus;

D O I：

10.1046/j.1365-2141.2002.34854.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：771 / 773

页数：3

共 4 条

[1] Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children [J].

Faye, A ;

Quartier, P ;

Reguerre, Y ;

Lutz, P ;

Carret, AS ;

Dehée, A ;

Rohrlich, P ;

Peuchmaur, M ;

Matthieu-Boué, A ;

Fischer, A ;

Vilmer, E .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (01) :112-118

[2]

TERAMURA T, 2002, IN PRESS LEUKEMIA LY

[3] Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoproliferative disease after allogeneic stem cell transplantation [J].

van Esser, JWJ ;

Niesters, HGM ;

Thijsen, SFT ;

Meijer, E ;

Osterhaus, ADME ;

Wolthers, KC ;

Boucher, CAB ;

Gratama, JW ;

Budel, LM ;

van der Holt, B ;

van Loon, AM ;

Löwenberg, B ;

Verdonck, LF ;

Cornelissen, JJ .

BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) :814-821

[4] Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma [J].

Vose, JM ;

Link, BK ;

Grossbard, ML ;

Czuczman, M ;

Grillo-Lopez, A ;

Gilman, P ;

Lowe, A ;

Kunkel, LA ;

Fisher, RI .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :389-397

← 1 →